![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Adaptimmune Therapeutics shares update on its late-stage clinical pipeline assets to treat cancer (Proactive Investors) View |
![]() |
ASCO Data and Clinical Update: 29 May 2020 (Adaptimmune Therapeutics) View |
![]() |
Adaptimmune (Alliance for Regenerative Medicine) View |
![]() |
SURPASS-2: investing ADP-A2M4CD8 SPEAR T-cell therapy to treat esophageal and GEJ cancers (VJOncology) View |
![]() |
ADAP Price and Volume Analysis by 650 Day Look Back ADAP Stock Analysis for Adaptimmune Therapeutics (TickerDD) View |
![]() |
What’s Next For Adaptimmune (Life Science Connect) View |
![]() |
Race Oncology secures governance approval for open-label Zantrene trial (Proactive Investors) View |
![]() |
GSK breaks up with Lyell Immuno u0026 Adapt Immune. What does this mean to CAR-T therapies (ShareTreck) View |
![]() |
Pharmaceutical Focus: Lung Therapeutics, Inc. (BGN - Blockchain Global News) View |
![]() |
Bridge Biotherapeutics @ Bio€quity Europe 2021 (Bridge Biotherapeutics Inc.) View |